A systematic review and meta-analysis of EPO in experimental stroke highlighted a reduction of infarct volumes by 30% and an improvement of neurobehavioral outcomes by 40% in rodents after EPO administration following AIS (Jerndal et al., 2010). This evidence concerns the gene EPO and Stroke.